A surface protection compound, in particular a compound for the non-flammable water-resistant non-hazardous biocidal surface protection of wood, or paper, or textile, or plastic, which contains an aqueous silicate solution which contains 93 to 98 wt % of an aqueous solution of potassium silicate, 1 to 6 wt % of aluminium hydroxide and, 0.5 to 1.5 wt % of stabiliser of the aqueous solution of potassium silicate.

A surface protection compound, in particular a compound for the non-flammable water-resistant non-hazardous biocidal surface protection of wood, or paper, or textile, or plastic, which contains an aqueous silicate solution which contains 93 to 98 wt % of an aqueous solution of potassium silicate, 1 to 6 wt % of aluminium hydroxide and, 0.5 to 1.5 wt % of stabiliser of the aqueous solution of potassium silicate.

The present application relates to cleaning and treatment compositions comprising a material that reduces foam and methods of making and using such material and compositions. Such compositions comprise benefit agents that typically impact the performance of antifoams yet in the present compositions antifoaming properties of antifoams are maintained.

The present application relates to cleaning and treatment compositions comprising a material that reduces foam and methods of making and using such material and compositions. Such compositions comprise benefit agents that typically impact the performance of antifoams yet in the present compositions antifoaming properties of antifoams are maintained.

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.

The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): ##STR00001##
wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.

The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): ##STR00001##
wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.

A mutant lysine decarboxylase produced by replacing at least one of the amino acids in SEQ ID NO:4 with another amino acid.

A mutant lysine decarboxylase produced by replacing at least one of the amino acids in SEQ ID NO:4 with another amino acid.